Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type

Guidance programme

HealthTech approach

HealthTech approach

Advice programme

Area of interest

Showing 526 to 550 of 2570

TitleReference numberPublishedLast updated
Lumasiran for treating primary hyperoxaluria type 1HST25
Daytime intraoral neuromuscular electrical tongue stimulation using a removable device for obstructive sleep apnoeaHTG672
Endoscopic ultrasound-guided biliary drainage for biliary obstructionHTG673
Hypertension in pregnancy: diagnosis and managementNG133
AposHealth for knee osteoarthritisHTG671
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal)TA879
Maximal cytoreductive surgery for advanced ovarian cancerHTG668
Radiofrequency ablation for palliation of painful spinal metastasesHTG669
Radiofrequency ablation as an adjunct to balloon kyphoplasty or percutaneous vertebroplasty for palliation of painful spinal metastasesHTG670
Percutaneous thoracic duct embolisation for persistent chyle leakHTG666
Focal therapy using high-intensity focused ultrasound for localised prostate cancerHTG667
UrgoStart for treating diabetic foot ulcers and leg ulcersHTG502
Macimorelin for diagnosing growth hormone deficiencyMIB320
Acute kidney injuryQS76
Finerenone for treating chronic kidney disease in type 2 diabetesTA877
Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancerTA876
CaRi-Heart for predicting cardiac risk in suspected coronary artery disease: early value assessmentHTG663
Type 1 diabetes in adultsQS208
Asfotase alfa for treating paediatric-onset hypophosphatasiaHST23
Endoluminal gastroplication for gastro-oesophageal reflux diseaseHTG661
Percutaneous transluminal renal sympathetic denervation for resistant hypertensionHTG662
Eptinezumab for preventing migraineTA871
Cannabidiol for treating seizures caused by tuberous sclerosis complexTA873
Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphomaTA874
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapiesTA872

Results per page

  1. 10
  2. 25
  3. 50
  4. All